How far can digital therapeutics go? Differences between Japan and the US in DTx regulations, insurance reimbursement, and penetration rates.

This podcast provides an overview of the current state of Digital Therapeutics (DTx), focusing on the differences in adoption and regulatory landscapes between the United States and Japan. It explores the challenges and opportunities for DTx, discussing factors like drug pricing, insurance reimbursement, regulatory approval processes, and the perspectives of both doctors and patients. The podcast also examines the potential for DTx in preventive medicine and different business models for its implementation.